Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance NASDAQ:CALA opened at $0.03 on Monday. Calithera Biosciences has a 1-year low of $0.01 and a 1-year high of $0.50. The company […]
More Stories
Adobe Inc. (NASDAQ:ADBE) Shares Acquired by Sound Income Strategies LLC
Sound Income Strategies LLC grew its holdings in Adobe Inc. (NASDAQ:ADBE – Free Report) by 17.6% in the 1st quarter,...
Pfizer Inc. (NYSE:PFE) Holdings Raised by Elevation Point Wealth Partners LLC
Elevation Point Wealth Partners LLC increased its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 15.9% in the 1st...
Dynamic Advisor Solutions LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE)
Dynamic Advisor Solutions LLC lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 9.6% in the first quarter,...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...
Brighton Jones LLC Cuts Stake in Kimberly-Clark Co. (NYSE:KMB)
Brighton Jones LLC lowered its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 6.0% in the first...